Adagio Therapeutics, Inc. License Agreements
3 Contracts & Agreements
- Amendment No. 2 to the Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated March 13, 2024 (Filed With SEC on March 28, 2024)
- Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated December 2, 2020 (Filed With SEC on July 16, 2021)
- Assignment and License Agreement by and between the Registrant and Adimab, LLC, dated July 8, 2020 (Filed With SEC on July 16, 2021)
